表紙:腫瘍分子診断の世界市場:業界動向、市場シェア、市場規模、成長、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1029143

腫瘍分子診断の世界市場:業界動向、市場シェア、市場規模、成長、機会、予測(2021年~2026年)

Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 145 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
腫瘍分子診断の世界市場:業界動向、市場シェア、市場規模、成長、機会、予測(2021年~2026年)
出版日: 2021年09月16日
発行: IMARC Services Private Limited
ページ情報: 英文 145 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腫瘍分子診断市場規模は、2021年から2026年の間に12.6%のCAGRで成長すると予測されています。

ライフスタイルの変化、高齢者人口の増加、喫煙者の増加などによるがんの罹患率の上昇は、世界の腫瘍分子診断市場の成長を促す大きな要因の一つとなっています。これに加えて、迅速かつ正確な診断に対する需要の高まりと、次世代シーケンシング(NGS)技術の進歩が市場の成長に寄与しています。

さらに、ウイルスや細菌による感染症にかかる人の数が増加していることや、献血キャンペーンへの参加者が増えていることも、世界の腫瘍分子診断薬の需要にプラスの影響を与えています。

当レポートでは、世界の腫瘍分子診断市場について調査しており、市場概要、市場分析、価格分析、競合情勢、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 序文

第2章 範囲および調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の腫瘍分子診断市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場の内訳:がんタイプ別

  • 乳癌
  • 前立腺癌
  • 結腸直腸癌
  • 子宮頸癌
  • 肝臓癌
  • 肺癌
  • 血液癌
  • その他

第7章 市場の内訳:製品別

  • 計器
  • 試薬
  • その他

第8章 市場の内訳:技術別

  • ポリメラーゼ連鎖反応(PCR)
  • インサイチュハイブリダイゼーション
  • チップとマイクロアレイ
  • 等温核酸増幅技術(INAAT)
  • 質量分析
  • DNAおよびNGSのシーケンス
  • 転写媒介増幅(TMA)
  • その他

第9章 市場の内訳:エンドユーザー別

  • 病院および診療所
  • リファレンスラボラトリー
  • その他

第10章 市場の内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東およびアフリカ
    • 市場の内訳:国別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Agilent Technologies Inc.
    • Abbott Laboratories
    • Bayer AG
    • BD(Becton, Dickinson and Company)
    • Cepheid Inc(Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Qiagen N.V.
    • Siemens Healthcare
    • Sysmex Corporation
図表

List of Figures

  • Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2020
  • Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2020
  • Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2020
  • Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2020
  • Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2020-2005
  • Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification- TMA) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
  • Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2021-2026
  • Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
  • Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Oncology Molecular Diagnostics Market Structure
  • Table 8: Global: Oncology Molecular Diagnostics Market: Key Players
目次
Product Code: SR1020F93_Report

The global oncology molecular diagnostics market is expected to grow at a CAGR of 12.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, cancer type, product, technology and end-user.

Breakup by Cancer Type:

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Others

Breakup by Product:

  • Instruments
  • Reagents
  • Others

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Chips and Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • DNA and NGS Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Abbott Laboratories, Bayer AG, BD (Becton, Dickinson and Company), Cepheid Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation. Key Questions Answered in This Report:

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prostate Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Liver Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Lung Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Blood Cancer
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Polymerase Chain Reaction (PCR)
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In Situ Hybridization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chips and Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Mass Spectrometry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 DNA and NGS Sequencing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Transcription Mediated Amplification (TMA)
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BD (Becton, Dickinson and Company)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Cepheid Inc (Danaher Corporation)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Qiagen N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens Healthcare
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis